SUJAY KANGO - 05 Jul 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Issuer symbol
MEIP
Transactions as of
05 Jul 2022
Net transactions value
$0
Form type
4
Filing time
07 Jul 2022, 16:19:52 UTC
Previous filing
31 Mar 2022
Next filing
12 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +87,500 $0.000000 87,500 05 Jul 2022 Common Stock 87,500 $0.5400 Direct F1
holding MEIP Stock Option (Right to Buy) 58,334 05 Jul 2022 Common Stock 58,334 $2.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in equal monthly installments over twelve months.
F2 25,000 options will vest in equal monthly installments over thirty-six months from November 22, 2021 and 33,334 options shall vest in equal monthly installments over twelve months from November 22, 2021.